Scott Kelly

Track

Insider profile

Currently holds a position at Cytodyn Inc

Performance

Overall performance
1.6
Performance over holding periods
1.6
30 days 90 days 120 days
Average return 9% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chairman of the Board Cytodyn Inc Dec. 12, 2018 -
Independent Director Cytodyn Inc April 1, 2017 - Dec. 12, 2018
Scott Kelly's trades of Cytodyn Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Cytodyn Inc (CYDY)
Transaction date
Sale
Price
219.93
Quantity 5,566 -39.9%
Value US$2,902,126
US Cytodyn Inc (CYDY)
Transaction date
Purchase
Price
441.77
Quantity 92,111 +24.4%
Value US$4,125,477
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2020-05-05 2020-05-01
US Cytodyn Inc (CYDY)
S Sale
5,566 -39.9%
219.93
US$2,902,126 		5,566 -39.9% 219.93 US$2,902,126
2020-05-05 2020-05-01
US Cytodyn Inc (CYDY)
B Purchase
92,111 +24.4%
441.77
US$4,125,477 		92,111 +24.4% 441.77 US$4,125,477